BET Inhibitors Reduce Cell Size and Induce Reversible Cell Cycle Arrest in AML

Inhibitors of the bromodomain and extra-terminal domain family (BETi) offer a new approach to treating hematological malignancies, with leukemias containing MLL rearrangements being especially sensitive due to a reliance on the regulation of transcription elongation. We explored the mechanism of act...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cell Biochem
Main Authors: Zhang, Susu, Zhao, Yue, Heaster, Tiffany M., Fischer, Melissa A., Stengel, Kristy R., Zhou, Xiaofan, Ramsey, Haley, Zhou, Ming-Ming, Savona, Michael R., Skala, Melissa C., Hiebert, Scott W.
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513713/
https://ncbi.nlm.nih.gov/pubmed/30417424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.28005
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki